New strategy for treating allergic disorders

---

Omschrijving
Oral intake of allergens via lactic acid bacterium Lactococcus lactis might be new strategy for treating auto-immune and allergic disorders. VIB researchers associated with Ghent University, in collaboration with Academic Medical Center, Amsterdam, have shown that auto-antigens or allergens can be administered orally via the lactic acid bacterium. Based on this principle, patented by VIB, ActoGeniX -- spin-off from VIB and Ghent University -- is developing a variety of biopharmaceutical medicines.

 

[ Ga naar het volledige artikel toe ]

Categorie: allergie

[Reinig uw lichaam met de Chlorella alg - 100% plantaardig ]

Het hoofdmenu
Nieuws
Supervoeding
Zoek op onderwerp